维普中文期刊产品整合服务
24篇 您的检索式:作者名="LEMINEN R"
    题名 作者 年代 出处 被引量
1FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype显示文摘Haltia UM BO tzow R Leminen A 2014J Gynecol Oncol2014,25,1:1
2Mifespritone may inhibit the mideyele gonadotropin surge at both ovarian and pituitary sites of action显示文摘HEIKINHEIMO O LEMINEN R RAIVIO T 2005Fertil Steril2005,84,5:1
3Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety显示文摘LEMINEN H HURSKAINEN R 2012Int J Womens Health2012,4,:1
4Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma显示文摘Koivisto-Korander R Leminen A Heikinheimo O 2007Obstet Gynecol2007,109,2:1
5Pharmacokineticsof 10mg of mifepristoner显示文摘Leminen R Ranta S Von Hertzen H 2003Contraception2003,68,6:1
6Mifespritone may inhibitthemideyele gonadotropin surge atboth ovarian and pituitary sites of action显示文摘Heikinheimo O Leminen R Raivio T 2005Fertil Steril2005,84,5:1
7Update on current care guidelines:ovarian cancer显示文摘Leminen A Auranen A Bützow R 20122012,,12:1
8Hereditary aspects of endometrial adenecarcinoma 显示文摘Suomi R Pietila THA Leminen A 1995Int J Cancer1995,62,:1
9Mifepristone may inhibit themidcycle gonadotropin surge at both ovarian and pituitary sites of action显示文摘Heikinheimo O Leminen R Raivio T 2005Fertil Steril2005,84,5:1
10Hereditary aspects of endometrial adenocarcinoma显示文摘Suoml R Pietila T Leminen A 1995Int J Cancer1995,62,:1
11Tranexamic acid for the treat?ment of heavy menstrual bleeding: efficacy and safety显示文摘Leminen H Hurskainen R 2012IntJ Womens Health2012,4,:1
12Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma显示文摘KOIVISTO-KORANDER R LEMINEN A HEIKINHEIMO O 2007Obstet Gynecol2007,109,22:1
13Ezrin immunoreactivity in relation to survival in serious ovarian carcinoma patients 显示文摘Moilanen J Lassus H Leminen A Vaheri A Butzow R Carpen O 2003Gynecol Oncol2003,90,2:1
14Late follicular phase administration of mifepristone suppresses circulating and FSH mechanisuts, of action in emergency antraception? 显示文摘Leminen R Raivic T Ranta S 2005Eur Endocrinol2005,152,3:1
15Pharmaeokineties of 10 mg of mifepristone 显示文摘Leminen R Ranta S Von Hertzen H 2003Contraception2003,68,6:1
16Pharmaeoki- netics of 10 mg of mifepristone 显示文摘LEMINEN R RANTA S VON HERTZEN H 2003Contraception2003,68,6:1
17FIGO 1988 versus 2009 staging for endometriai carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype显示文摘HALTIA U M Bt2TZOW R LEMINEN A 2014Journal of Gynecologic Oncology2014,25,1:1
18Hereditary aspects of endomitrial adenocarcinoma显示文摘Suomi R Pietila T Leminen A 1995Int J Cancer1995,62,1:1
19Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome显示文摘Renkonen-Sinisalo L Btltzow R Leminen A 2007Int J Cancer2007,120,4:1
20Hereditary aspects ofendometrial adenocarcinoma显示文摘Suomi R Pietila T Leminen A 1995Cancer1995,62,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费